Chronic Total Occlusion of Left Main Stem with Multi-vessel Disease


  • Irfan Muhammad Fauji Foundation Hospital Peshawar-Pakistan


Chronic total occlusion, left main stem, multi-vessel disease, angioplasty, stenting, long-term outcomes.


Background: Chronic total occlusion (CTO) of the left main stem (LMS) presents a challenging scenario in the management of coronary artery disease. We present a case highlighting the successful intervention and long-term outcomes in a 70-year-old male with CTO of the LMS and multi-vessel disease, complicated by non-ST-segment elevation myocardial infarction (NSTEMI) and severely impaired left ventricular (LV) function.

Case Presentation: A 70-year-old hypertensive male presented with NSTEMI, severe LV dysfunction, moderate mitral regurgitation, and hypotension. Despite initial hesitation towards intervention, recurrent chest pain necessitated urgent coronary angiography. Diagnostic assessment revealed electrocardiographic changes suggestive of ischemia and echocardiographic evidence of LV dysfunction.

Management & Results: Therapeutic intervention involved meticulous pre-dilatation of the occluded LMS followed by angioplasty and stenting, with attention to avoid bifurcation stenting. Additional interventions included balloon angioplasty and stenting of proximal lesions in the left anterior descending (LAD) artery and ramus, and direct stenting of the distal right coronary artery (RCA) lesion. Long-term follow-up demonstrated significant improvements in clinical symptoms and LV function, emphasizing the efficacy of revascularization.

Conclusion: This case underscores the importance of timely intervention, tailored therapeutic approaches, and long-term medication adherence in optimizing outcomes in patients with complex coronary artery disease and impaired LV function. A simplified approach to multi-vessel percutaneous coronary intervention may offer favorable long-term outcomes, warranting further investigation.


Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann FJ, Robertson DH, DeLucca PT, DiBattiste PM, Gibson CM, Braunwald E; TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)--Thrombolysis in Myocardial

Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001 Jun 21;344(25):1879-87. doi: 10.1056/NEJM200106213442501. PMID: 11419424.

Boden WE, McKay RG. Optimal treatment of acute coronary syndromes--an evolving strategy. N Engl J Med. 2001 Jun 21;344(25):1939-42. doi: 10.1056/NEJM200106213442510. PMID: 11419433.

Throckmorton DC. Future trials of antiplatelet agents in cardiac ischemia. N Engl J Med. 2001 Jun 21;344(25):1937-9. doi: 10.1056/NEJM200106213442509. PMID: 11419432.

Topaz O. Ischemic coronary syndromes and SVG Interventions--do 2b/3a inhibitors miss the target? Catheter Cardiovasc Interv. 2007 Apr 1;69(5):630-1. doi: 10.1002/ccd.20985. PMID: 17377986.




How to Cite

Muhammad, I. (2024). Chronic Total Occlusion of Left Main Stem with Multi-vessel Disease. Cathalogue, 2(1), 35–42. Retrieved from